FU
FUJIY.US FUJIFILM Holdings Corp
- Market cap
- USD 27.0B
- P/E
- 16.4x
- P/B
- 1.11x
- ROE
- 3.6%
- Dividend yield
- 1.91%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is FUJIY.US undervalued?
Graham numberFUJIY.US trades 10.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
FUJIFILM Holdings Corp fundamental analysis
No fundamental analysis for FUJIFILM Holdings Corp yet.
FUJIFILM Holdings Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About FUJIFILM Holdings Corp
FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and mater…
Full company profileFUJIFILM Holdings Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
FUJIFILM Holdings Corp annual financial statements
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.32T | 2.43T | 2.43T | 2.32T | 2.19T | 2.19T | 2.86T | 2.96T | 3.20T | 3.56T | 284T |
| Gross Profit | 931B | 970B | 998B | 954B | 870B | 1.03T | 1.14T | 1.19T | 1.30T | 1.45T | 118T |
| Operating Income | 172B | 131B | 210B | 187B | 165B | 165B | 273B | 277B | 330B | 371B | 28.8T |
| EBITDA | 317B | 330B | 346B | 320B | 298B | 362B | 429B | 476B | 513B | 554B | 28.9T |
| Net Income | 132B | 141B | 138B | 125B | 181B | 181B | 219B | 244B | 261B | 293B | 21.7T |
| EPS | 148 | 161 | 163 | 305 | 221 | 226 | 46 | 101 | 108 | 122 | 9,082 |
| Balance Sheet | |||||||||||
| Total Assets | 3.53T | 3.49T | 3.41T | 3.32T | 3.55T | 3.96T | 4.13T | 4.78T | 5.25T | 6.08T | 964T |
| Total Liabilities | 1.27T | 1.19T | 1.17T | 1.33T | 1.33T | 1.43T | 1.35T | 1.61T | 1.90T | 2.22T | 361T |
| Shareholders' Equity | 2.04T | 2.08T | 2.04T | 1.99T | 2.20T | 2.20T | 2.76T | 3.17T | 3.35T | 3.86T | 603T |
| Cash & Short-term Investments | 882B | 768B | 655B | 396B | 395B | 395B | 269B | 180B | 172B | 171B | 23.0T |
| Total Debt | 582B | 479B | 552B | 703B | 703B | 610B | 537B | 608B | 802B | 1.03T | 177T |
| Cash Flow | |||||||||||
| Operating Cash Flow | 289B | 261B | 249B | 256B | 421B | 324B | 210B | 408B | 428B | 435B | 62.2T |
| Capital Expenditure | 97.0B | 81.6B | 89.0B | 110B | 126B | 166B | 323B | 465B | 558B | 553B | 65.2T |
| Free Cash Flow | 192B | 180B | 160B | 146B | 295B | 158B | -113B | -56.8B | -130B | -118B | -2.96T |
| Ratios | |||||||||||
| ROE | 6.4% | 6.8% | 6.8% | 6.3% | 8.2% | 8.2% | 7.9% | 7.7% | 7.8% | 7.6% | 3.6% |
| ROA | 3.7% | 4.0% | 4.0% | 3.8% | 5.1% | 4.6% | 5.3% | 5.1% | 5.0% | 4.8% | 2.3% |
| Net Profit Margin | 5.7% | 5.8% | 5.7% | 5.4% | 8.3% | 8.3% | 7.7% | 8.2% | 8.2% | 8.2% | 7.6% |
| Debt to Equity | 0.29x | 0.23x | 0.27x | 0.35x | 0.32x | 0.28x | 0.19x | 0.19x | 0.24x | 0.27x | 0.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
FUJIFILM Holdings Corp dividends
- Dividend yield
- 1.91%
- Forward dividend
- 0.22 USD
- Payout ratio
- 30.5%
- Ex-dividend date
- Mar 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 89.4B | 37 | 30.5% |
| 2025 | JPY 68.3B | 28 | 26.2% |
| 2024 | JPY 56.2B | 23 | 23.1% |
| 2023 | JPY 46.1B | 9.57 | 21.0% |
| 2022 | JPY 43.0B | 54 | 23.7% |
| 2021 | JPY 38.0B | 46 | 21.0% |
| 2020 | JPY 35.8B | 87 | 28.7% |
| 2019 | JPY 33.2B | 39 | 24.0% |
| 2018 | JPY 31.7B | 36 | 22.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6:1 on Apr 2, 2024.
Who owns FUJIFILM Holdings Corp
- Insiders 0.00%
- Institutions 0.07%
- Public & others 99.94%
- Shares outstanding 2.39B
- Free float 2.39B
FUJIFILM Holdings Corp company profile
- Company name
- FUJIFILM Holdings Corp
- Ticker
- FUJIY.US
- Exchange
- USA Stocks
- Listed since
- May 1, 1949
- Sector
- Industrials
- Industry
- Technology Hardware, Storage & Peripherals
- Employees
- 73,526
- Fiscal year end
- March
- Address
- 7-3, Akasaka 9-chome, Minato, Japan, 107-0052
- Phone
- 81 3 6271 1111
- Website
- holdings.fujifilm.com
About FUJIFILM Holdings Corp
FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents. The Electronic segment provides display and touch panels, semiconductors and image sensors, and functional film materials; storage media and archiving services; semiconductor and display materials; industrial equipment; and fine chemicals. Its Business Innovation segment offers office equipment, including multi-function devices and printers; problem-solving document services tailored to diverse business formats and roles, including system integration, cloud service, business process outsourcing, and others; equipment and materials for graphic communications; and inks and industrial inkjet printheads. Its Imaging segment provides color films, instant cameras, developing and printing systems, color papers, and photo printing services; TV and cinema lenses, surveillance cameras, industrial lenses for production line inspection, and projectors; instant photo systems; services for photofinishing; digital cameras; and optical devices. FUJIFILM Holdings Corporation was incorporated in 1934 and is headquartered in Minato, Japan.
FUJIFILM Holdings Corp management
10- Mr. Kenji SukenoExecutive Chairman of The Board · born 1954
- Mr. Teiichi GotoPresident, CEO & Representative Director · born 1959
- Mr. Masayuki HiguchiCorporate VP, GM of Corporate Planning Division, Accounting and Finance Div, CFO & Director · born 1963
- Ms. Chisato YoshizawaCorporate VP, GM of Corp Communications and ESG Division-Global Audit Dep, Brand Mgmt & Director · born 1963
- Toshiyuki MorishimaCorporate Vice President & GM of Accounting and Finance Div.
- Mr. Yoji ItoCorporate Vice President and CTO & Director · born 1964
- Atsushi SakuraiCorporate VP & GM of Legal Division
- Yasushi ZamaCorporate VP and GM of Human Resources Division & Corporate General Administration Division
- Naoko SakumaCorporate Vice President & GM of Intellectual Property Division
- Ms. Tomoyuki HasegawaCEO of FUJIFILM Biotechnologies California & GM of Fujifilm Life Sciences Strategic Office